A novel methylation signature predicts inferior outcome of patients with PDAC

Pancreatic ductal adenocarcinoma (PDAC) will become the second most common cause of death in North America and Europe over the next 10 years owing to the lack of early diagnosis, poor treatment, and poor prognosis. This study evaluated the methylation array data of 184 patients with PDAC in The Canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Minqi, Sun, Jing, Zhang, Shunhao, Chen, Jing, Wang, Guihua, Ju, Shaoqing, Wang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880369/
https://www.ncbi.nlm.nih.gov/pubmed/33550277
http://dx.doi.org/10.18632/aging.202347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880369/
https://www.ncbi.nlm.nih.gov/pubmed/33550277
http://dx.doi.org/10.18632/aging.202347

Ejemplares similares